411 related articles for article (PubMed ID: 26759260)
21. The FHL2 regulation in the transcriptional circuitry of human cancers.
Cao CY; Mok SW; Cheng VW; Tsui SK
Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
[TBL] [Abstract][Full Text] [Related]
22. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
Li S; Jiao J; Lu Z; Zhang M
Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
[TBL] [Abstract][Full Text] [Related]
23. Targeting the ZMIZ1-Notch1 signaling axis for the treatment of tongue squamous cell carcinoma.
Pang Y; Sun Y; Wu Y; Li J; Qin P; Guo S; Zhou W; Chen J; Wang J
Sci Rep; 2024 Jun; 14(1):13577. PubMed ID: 38866828
[TBL] [Abstract][Full Text] [Related]
24. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
25. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
[TBL] [Abstract][Full Text] [Related]
26. FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest.
Ren W; Lian P; Cheng L; Du P; Guan X; Wang H; Ding L; Gao Z; Huang X; Xiao F; Wang L; Bi X; Ye Q; Wang E
Mol Med Rep; 2015 Sep; 12(3):3958-3964. PubMed ID: 26017856
[TBL] [Abstract][Full Text] [Related]
27. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
Qiu K; Huang Z; Huang Z; He Z; You S
Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
[TBL] [Abstract][Full Text] [Related]
28. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
29. Tumoral expression of nuclear cofactor FHL2 is associated with lymphatic metastasis in sporadic but not in HNPCC-associated colorectal cancer.
Al-Nomani L; Friedrichs J; Schüle R; Büttner R; Friedrichs N
Pathol Res Pract; 2015 Feb; 211(2):171-4. PubMed ID: 25554651
[TBL] [Abstract][Full Text] [Related]
30. FHL2 participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via regulating the β-catenin pathway.
Zhou SG; Ma HJ; Guo ZY; Zhang W; Yang X
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2734-2741. PubMed ID: 29771425
[TBL] [Abstract][Full Text] [Related]
31. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
[TBL] [Abstract][Full Text] [Related]
33. The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells.
Wong CH; Mak GW; Li MS; Tsui SK
Cytokine; 2012 Aug; 59(2):286-93. PubMed ID: 22633286
[TBL] [Abstract][Full Text] [Related]
34. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
[TBL] [Abstract][Full Text] [Related]
35. Expression, location and biological effects of four and a half LIM domain protein 2 (FHL2) on granulosa cells in ovine.
Zhang L; Li R; Chen L; Xing Z; Song Y; Nie X; Wang L; Han H; Liu A; Ma X; Ma RZ; Tian S
Reprod Domest Anim; 2020 Jun; 55(6):737-746. PubMed ID: 32181932
[TBL] [Abstract][Full Text] [Related]
36. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
[TBL] [Abstract][Full Text] [Related]
37. Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer.
Verset L; Tommelein J; Moles Lopez X; Decaestecker C; Mareel M; Bracke M; Salmon I; De Wever O; Demetter P
Br J Cancer; 2013 Jul; 109(1):114-20. PubMed ID: 23756870
[TBL] [Abstract][Full Text] [Related]
38. FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.
Zheng X; Jia B; Lin X; Han J; Qiu X; Chu H; Sun X; Hu W; Pan J; Chen J; Zhao J
Int J Mol Med; 2016 Nov; 38(5):1443-1449. PubMed ID: 27666346
[TBL] [Abstract][Full Text] [Related]
39. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
[TBL] [Abstract][Full Text] [Related]
40. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
